Jill Feldman: As we anxiously await data to read out at ASCO24, please remember, People Come First!

Jill Feldman shared a post on X/Twitter:

”As we anxiously await data to read out at ASCO24, please remember, People Come First!

Mary Boulanger will present her work that highlights prognostic communication challenges and patients’ unmet psychosocial needs – both JUST AS IMPORTANT as Overall Survivals and Hazard Ratios.”

Source: Jill Feldman/X

Jill Feldman is a lung cancer patient and advocate. She is the Co-Founder EGFR Resisters, an advocacy group of EGFR positive lung cancer patients who are resistant to targeted treatment. She is the Past President of the LUNGevity Foundation, Deputy Chair of IASLC’s patient advisory board and a member of The Chicago Institute of Translational Medicine’s patient advisory board. Jill is committed to understanding and promoting patient-centered research as a member of the programmatic panel for the Department of Defense Lung Cancer Research Program, as a planning committee member on IASLC’s North America Conference on Lung cancer and as a member of the the ECOG-ACRIN Research Group’s patient advocate committee and thoracic committee..